We showed that SOX2 and NTRK2 double-positive expression is associated with the outcome of NPC patients, and that they are crucial genes found to be highly expressed in NR cells – a subset of cells exhibiting resistance to lytic induction in NPC43. The gene discussed is SOX2; the disease is nasopharyngeal carcinoma.